Webinar

Future lab, AI and digital data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab automation #Machine learning #Webinar

AI & Lab Automation: What are the key benefits and latest innovations?

In this webinar, hosted by DDW and co-sponsored by Benchling and Proscia, you will learn about the key benefits and latest innovations to be aware of in AI and lab automation. You will hear from Jeremy Skillington, CEO of Poolbeg Pharma, as well as sponsor presentations from Helen Liu-Mayo, Product… Read More

Webinar date:
Co-sponsored by Benchling and Proscia
#Webinars

Future lab, AI and digital data
#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Webinar: Key benefits and latest innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

iPSC derived cells for developing drug and gene therapies

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News

Stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

How can iPSC derived cells can be used to support drug development?

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News

#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

Register now: Why are ADME and DDI investigations important?

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

How do iPSC derived cells support development of gene therapies?

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models to simulate… Read More

Webinar date:
Supported by DefiniGEN
#Webinars

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

ADME and DDI considerations during drug development

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Medical researcher
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

ADME and DDI considerations during drug development

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

Learn about ADME and DDI considerations in drug discovery

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Further insight into breakthroughs in mRNA drug discovery 

DDW recently hosted Where are the breakthroughs in mRNA drug discovery and development? In this webinar, sponsored by Elegen, attendees learnt about the breakthroughs in mRNA drug discovery and development. Watch this on demand now.   Due to technical difficulties, Carsten Rudolph, Managing Director and CEO of Ethris, was unable to… Read More

#Exclusive Content

microRNA
#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Webinar: The breakthroughs in mRNA drug discovery

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

What does the future hold for mRNA therapeutics? Register now

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Gene therapy
#AAV #Azenta Life Sciences #Drug development #Drug discovery #Gene therapy #Webinar

Learn how to use adeno-associated virus (AAV) vectors in gene therapy

Join DDW for this exclusive free event, A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences.  AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV… Read More

#News

RNA
#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Learn about the opportunities in mRNA drug discovery

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News